How Can We Help You?

Quick Info:

Find a Doctor Specialties (800) 213-3284

Go To Home PageBack

Uterine Fibroids

Select Clinical Trial

ObsEva 16-OBE2109-008 – Phase 3, multicentre, randomized, double-blind, placebo-controlled study investigating the efficacy and safety of daily oral administration of OBE2109 alone and in combination with add-back therapy for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women

  •  Premenopausal women over 18, with menstrual cycles 21-40 days 
Specialties
Clara McLean House
Make a Donation
News & Events